Skip to main content

Femasys Inc

FEMY
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001339005

In the last 90 days, Femasys Inc insiders filed 5 open-market purchases and 0 sales; 19 institutions reported holding it in 13F filings for Q2 2026, worth $8.65M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Femasys Inc changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of FEMY: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders1617+1
Shares518.8K821.6K+302.9K (+58.4%)
Value$2.02M$1.86M−$167.0K (−8.3%)

New holders (6)

Institutions that held Femasys Inc at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to FEMY in Q1 2022
InstitutionSharesValue% of portfolio
Vanguard Group Inc119,185$269.0K0.00%
First National Corp74,296$168.0K0.04%
Cambridge Investment Research Advisors, Inc.29,881$68.0K0.00%
Freedman Financial Associates, Inc.21,032$45.0K0.03%
Cetera Advisor Networks LLC12,000$27.0K0.00%
JPMorgan Chase & Co120$00.00%

Sold out (5)

Institutions that held Femasys Inc at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of FEMY in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
First Republic Investment Management, Inc.18,286$71.0K
Baird Financial Group, Inc.14,666$57.0K
Virtu Financial LLC12,894$50.0K
Jane Street Group, LLC11,515$45.0K
Bank of America Corp4$0